Skip to main content
SpringerLink
Log in

Aflibercept/bevacizumab/ranibizumab

No improvement

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yuan PH, et al. Brolucizumab after failure of aflibercept with photodynamic therapy in polypoidal choroidal vasculopathy: A case report. Archivos de la Sociedad Espanola de Oftalmologia (English Edition) 98 : 713-717, No. 12, Dec 2023. Available from: URL: https://dx.doi.org/10.1016/j.oftale.2023.10.009

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aflibercept/bevacizumab/ranibizumab. Reactions Weekly 2002, 26 (2024). https://doi.org/10.1007/s40278-024-55403-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55403-3

Search

Navigation